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We have previously shown that cationic proteins lo-
calize to the dermal-epidermal junction (DEJ) after i. v. 
injection in experimental animals. In the present studies, 
cationized rabbit lgG was used as antigen for induction 
of chronic serum sickness in C57BL/6J mice over a 
period of 4 weeks. The formation of immune deposits 
was examined by immunofluorescence microscopy at 
weekly intervals during chronic antigen administration 
and at 7 weeks from the initiation of studies. 
Chronic administration of the cationized antigen led 
to hnmune complex deposits at the DEJ, while admin-
istration of the same antigen in native form did not lead 
to these deposits. Junctional immune deposits increased 
with higher doses of cationized antigen and paralleled 
renal extraglomular deposition in intensity, persistence, 
and morphology. Mice given cationized antigen also 
demonstrated vascular immune complex deposits with-
out complement, while mice given native antigen had 
complement deposits and developed perivascular in-
flammation. No inflammation or complement deposition 
was detected at the DEJ in either group. 
Charge properties of circulating antigens are impor-
tant in determining tissue sites of immune complex dep-
osition and inflammation. Circulating cationic antigens 
can lead to immune deposits at the DEJ. 
Deposit ion of circulating immune complexes, as a cause of 
inflammatory human dermal disorders, has been suspected in 
a number of skin diseases [1]. Opie [2], in 1924, showed that 
the local inflammation produced by intradermal injection of 
egg albumin in rabbits depended on the antibody titer, impli-
cating immune complexes in the induction of inflammation. In 
animal models of acute and chronic serum sickness, investiga-
tors have demonstrated the occurrence of vascular lesions in 
t issues of rabbits [3]. mice [4], and guinea pigs [5]. Dixon eta! 
[6] demonstrated the presence of both antigen and antibody in 
these vascular lesions, again implicating immune complexes in 
their pathogenesis. 
In these experimental models, no comments were made about 
cutaneous deposition of immune complexes and inflammation 
of the skin. Rich and Gregory noted "petechiae" in several 
rabbits that developed vascular lesions after immunization with 
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horse serum [3]. These animals developed inflammation in 
tissues such as heart, bladder wall, and testis, but no comments 
were made on skin inflammation. However, a cutaneous Arthus 
reaction could be induced simultaneously with the spontaneous 
appearance of lesions in other organs [7] , or when free antibody 
appeared in circulation (6]. In a large study, Brentjens et al (8] 
examined 161 rabbits chronically immunized with bovine serum 
albumin and found no dermal-epidermal junctional deposits. 
Mice immunized chronically with oral ovalbumin developed 
renal lgA deposits but no skin deposits [9]. 
We have previously shown in mice that cutaneous localiza-
tion of immune complexes is related to immune complex lattice 
and charge, in that large-latticed immune complexes formed 
with cationic antibodies deposit and persist at the dermal-
epidermal junction [10] . In the present studies we have induced 
chronic serum sickness in mice with native or cationic rabbit 
lgG as antigens, and have followed the antibody response as 
well as tissue deposition, wit h particular attention to the dermal 
vessels and dermal-epiderma l junction (DEJ). 
MATERIALS AND METHODS 
Preparation and Characterization of Native, Aggregated, and 
Cationized. Antigen 
Rabbit monomeric IgG (RlgG) was purified from rabbit fraction II 
(Miles Laborato ries, Elkhart, Indiana) by gel filtration over a Sephadex 
G-200 column (Pharmacia Fine Chemicals Pharmacia, Inc., Piscata-
way, New J ersey) , equilibrated with pH '8.0 borate-buffered saline 
(BBS) consisting of 0.2 M borate, and 0.15 M NaCI. Aliquots of t~e 
purified RlgG were heat aggregated in a water bath at 63•C for 10 mm 
to render this material more immunogenic. Cationic RlgG (RigGED) 
was prepared by ethylene diamine linkage to reactive carboxyl groups 
by a water-soluble carbodiimide reaction, as previously described [ 11). 
A t rini trobenzene-sulfonic acid (TNBS) assay was performed as de-
scribed by Habeeb [12) and modified by Gauthier et al [11). Some 
preparations were trace- labeled with 1251 as previously described [11] . 
The antigen preparations were characterized on linear 10- 30% su-
crose density gradients as previously described [10). 
lsoelectric focusing was performed on a Pharmacia flat bed apparatus 
(Pharmacia Fine Chemicals) using standard procedures [11). Focusmg 
was performed with 20-1Il samples at 20 W for 1.5 h after 0.5 h of 
prefocusing. The gel was stained for 1- 2 h with Coomass1e Blue and 
destained overnight before drying. 
Determination of Seru.m Antibody Levels Du.ring the Cou.rse of 
I mmu.nization 
A radioimmunoassay was employed to assess the serum antibody 
level. Tests were performed in duplicate. Ten-microliter samples of test 
sera were added to 1.0 11g and 0.1 11g of [125I)RJgG in 10 11l of BBSm a 
1.5-ml microfuge tube (Beckman Instruments, Inc. , Palo Alto, Cahfor-
nia). The samples were allowed to react in a water bath at 37·c for 1 
h prior to the addition of 80 11l of goat antimouse IgG (N. L. Cappel 
Laborato ries, Cochranville, Pennsylvania) t hat had been passed over a 
Sepharose CL4B-RigG affinity column to remove antibodies reactive 
with RigG. The samples were again allowed to react for 1 h at 37•c 
and were then stored for 16 h at 4 · c prior to centrifugation at 10,000 
rpm for 5 min in the Beckman Microfuge 12 (Beckman Instruments, 
Inc.) Percent bound was calculated by determining t he radioactivity of 
the 50 11l supernatant (S) and 50 11l residual (R) fraction as (R - S/R 
+ S) X 100. 
The assay was standardized with sera from mice immunized by the 
same experimental protocol, and collected 2 weeks after the initiation 
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of immunization. The concentration of the serum was adjush;d to 
precipitate approx imate ly 50% of0.1 11g RlgG and s 50% of 1 11g RigG. 
In separate experiments 80 11l of the prepared goat antimouse lgG 
precipi tated greater than 95 % of 100-11g samples of radiolabeled mouse 
lgG in 10 J1.1 BBS, and 5 Jl.g of labeled mouse IgG added to 10-Jl.l samples 
of normal mouse sera, and precipitated less than 10% of 1.0 or 0.1 11g 
of labeled RlgG in BBS. 
Immunofluorescence Microscopy, Histology, and Electron Microscopy 
Skin from tai l, lip, fl ank, and ear, and renal tissue were obtained 
afte r sacrifice of mice. These tissues were embedded in Tissue Tek 11 
OCT (Ames Company, Elkhart, Indiana) and frozen. Four-micrometer 
sections were cut, stained, examined, and graded as previously desc ribed 
(10] . The fo llowing 11uoresceinated antisera were used: goat antirabbit 
lgG (Kallestad Laboratories, Austin, Texas); goat antimouse C3 and 
goat ant imouse IgG (N. L. Cappel Laboratories). T he antisera were 
furth er purified with either RlgG or mouse whole-serum columns to 
render them monospecific. The specificity was verified with agarose-
antigen beads as previously described [13]. A grading scale (0 to 4+) 
was used as previously described for kidney [11] and skin [12]. Briel1y 
the scoring fo r skin was: 4+, dense deposits visible at lOOX; 3+ , dense 
deposits visible in most fields at 400x; 2+, dense deposits visible in 
some fi elds (10- 50%) at 400x; 1+, deposits visible in less than 10% of 
fi elds at 400x; trace, fai nt deposits visible in some fie lds at 400X. A 
Zeiss 11uorescence microscope (Zeiss, Oberkochen, F.R.G.) was used. 
Photographs were taken on T ri -X Pan ASA 400 film (Eastman Kodak, 
Rochester, New York) with a 30-s exposure time. 
For histology, tissues were stored in gluta raldehyde/cacodylate 
buffer (0.1 M sodium cacodylate , 6% glutaraldehyde) at 4"C. Tissues 
were cut in 4-Jl.m sections and stained with hematoxylin and eosin. A 
grading scale of 0 to 3+ was used: 0, no inflammatory cells; 1+, 1- 3 
inflammatory cells; 2+, 4- 10 cells; and 3+ , greater than 10 cells around 
individual blood vessels at 400x. 
Electron microscopy was performed on kidney sections as previously 
described [14] . 
Experimental Design. 
Female C57BL/6J mice (Jackson Laborato ries, Bar Harbor, Maine) 
were divided into 4 groups. All animals received a primary immuniza-
t ion with 1.0 mg of heat-aggregated RigG in complete Freund 's adju-
vant s.c. on day - 14 and were boosted at day -7 with 1.0 mg of heat-
aggregated RlgG in incomplete Freund's adjuvant. Chronic ta il vein 
injections were begun 1 week later, on day 0. The first group rece ived 
l.O mg RigG in 0.5 ml BBS chronic i.v. injections on Monday, Wednes-
day, and Friday. The second group received 1.0 mg RigGEIJ, the third 
group 5.0 mg RlgG 8n, and the fourth group 0.5 ml BBS only, all on the 
same schedule. Injections were continued for 4 weeks. Three mice in 
each group were sacrificed at weeks 1, 2, 3, and 4, 16 h after the last 
injection. T hree mice in each group were sacrificed at 7 weeks, i.e., 3 
weeks afte r the fin al injection of ant igen. In separate experiments, 2 
mice were sacrificed at weeks 1, 2, 3, and 4, 4 h after the last injection 
of antigen. 
Urine sa mples were checked at the end of each week for protein wit h 
Uristix (Ames Company). Fifty-microliter samples of blood were ob-
ta ined from retroorbital plexus prior to injections on Mondays, and the 
harvested serum was stored at -70"C. 
RESULTS 
Characterization of Antigens 
RlgG a nd R igGED were shown to be monomeric on sucrose 
density gradients (SDGs). In heat-aggregated RigG, 45% of 
protein radioactiv ity sedimented faster t h an 7S. The TNBS 
assay showed the average number of added amino groups on 
RigGr,:D to range from 20- 30. On isoelectric focusing t he major-
ity of RigGw had a pi greater than 9.3 with a trai ling edge of 
less a ltered protein. 
Dermal Localization of Immune Deposits and Inflammation 
All tissues were stained with fluoresceinated goat antimouse 
IgG, goat a ntimouse C3, and goat antii abbi t lgG. Most sections 
of skin from different locations stained s imilarly, but where 
regional diffe rences occurred t his is noted . 
At t he DEJ, RlgG as an t igen was ident ifiable only after t he 
chronic administration of cationized RlgG. RlgG was detected 
consistently at t r- 1+ levels in t he RigGED (1 mg) group and at 
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1-2+ levels in the RigGED (5 mg) group a nd was not detected 
in una ltered RlgG- or BBS-treated groups (Table 1) . Diffuse 
dermal deposits without clear vascular patterns occurred in the 
RigG (1 mg), RigGED (1 mg), and RigGED (5 mg) groups at tr-
1 + levels. The same t issues were also examined for t he presence 
of mouse IgG and mouse C3. The mice given RigGEo showed 
mouse lgG deposits at the DEJ after antigen administration 
that increased with t ime and with higher dose of antigen. The 
RigG ED (1 mg) group had depos its increasing from 0-tr at 1 
week, 1- 2+ at 2 weeks, to 1-2.5+ at 3 weeks, 1-1.5+ at 4 weeks, 
and declined to near trace levels at 7 weeks, 3 weeks after 
antigen injections were stopped (Table II). There was slight 
regional variation in positivity, most marked at 3 weeks (Fig 
TABLE l. Immunofluorescence intensity for rabbit IgG at the 
dermal-epidermal junction. of skin" 
1 Week 2 Weeks 3 Weeks 4 Weeks 7 Weeks 
RigGED (1 mg) tr tr 1+ 1+ tr 
RigGED (5 rng) 1+ 1+ 2+ 2+ 1+ 
RlgG (1 mg) 0 0 0 0 0 
BBS 0 0 0 0 0 
"Sacrificed 16 h after last dose. 
TABLE 11. Skin immunofluorescence intensity for mouse lgG at the 
dermal-epidermal junction of skin" 
1 Week 2 Weeks 3 Weeks 4 Weeks 7 Weeks 
RigGED (1 mg) 
Flank 0- tr 1+ 1+ 1+ tr 
Ear 0- tr 1.5+ 2+ 1+ 0-tr 
Lip 0- tr 1.5+ 1.5+ 1.5+ t r 
Tail 0- tr 2+ 2.5+ 1.5+ tr-1 + 
RigGED (5 mg) 
Flank tr 2+ 2.5+ 2+ 1+ 
Ear tr 1+ 2+ 2+ 1.5+ 
Lip 0.5+ 1+ 2.5+ 1.5+ 1+ 
Tail 0.5+ 1.5+ 2+ 1+ 1+ 
RlgG (1 mg) 0 0 0 0 0 
BBS 0 0 0 0 0 
"Sacrificed 16 h afte r last dose. 
FIG 1. Skin immunofluorescence patterns after staining with t1u-
oresceinated antimouse lgG. After 3 weeks of chronic injections with 1 
mg of cationized rabbit IgG, dermal-epidermal immune deposits (ar-
rows) have fo rmed in the ear (A) , lip (B), tai l (C), and t1ank (D). 
X 400. 
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1), when the flank remained 1+ and the tail was 2.5+. With 
the 5-mg dose of RigGED more deposits were found at most 
time points with tr- 0.5+ at 1 week, 1-2+ at 2 weeks, 2-2.5+ at 
3 weeks, 1- 2+ at 4 weeks, and 1.5+ at 7 weeks, again 3 weeks 
after injections were stopped (Fig 2). With the injection of 
unaltered RigG and in the control group given only buffer, no 
deposits of mouse IgG were found at the DEJ. All skin speci-
mens were examined for vascular and interstitial deposits of 
mouse IgG, but only tr- 1 +deposits were found inconsistently 
in the 2 RigGED and the RigG groups over the course of the 
experiment. Mouse C3 was not detected in any skin sections. 
Because we found perivascular inflammation without demon-
str able immune deposits, we subsequently sacrificed mice 4 h 
(instead of 16) after the last injection of antigen. The RlgG (1 
mg) group had granular vascular deposits of antigen, antibody, 
and complement at this time point (Table III) . The RigGED (1 
mg) group had more diffuse perivascular and trace junctional 
deposits of antigen and antibody without complement (Fig 3). 
For comparison, in the same mice deposition of the antigen 
and mouse IgG and mouse C3 was examined in glomeruli and 
interstitial areas. The deposits of rabbit lgG were comparable 
to t he deposits of mouse IgG (Table IV). In the RigGED (1 mg) 
group, deposition increased from 2+ at 1 week, to 2.5+ at 2 
weeks, 3+ at 3 weeks, 2.5+ at 4 weeks, and remained as intense 
at 7 weeks (Fig 4). A glomerular capillary loop pattern predom-
inated with extraglomerular tubular basement membrane stain-
ing as well: 1 + at 1, 2, and 3 weeks, and declined thereafter. 
The RigGED ( 5 mg) group had more intense deposits at all 
t ime points than the RigG ED (1 mg) group: 2+ at 1 week, 3.5+ 
at 2 weeks, 4+ at 3 and 4 weeks, and 3+ at 7 weeks. Extraglo-
merular staining in the RigGED (5 mg) group was 2+ through-
out. The glomerular pattern again showed capillary loop with 
tubular basement membrane staining. The RigG (1 mg) group, 
in contrast, had lesser deposition only in a mesangial pattern: 
1.5+ at 1 week, and 2+ at all later time points. Furthermore, 
no extraglomerular staining was found in this group. Mouse C3 
was found at tr-1 + levels in the RigGED (1 mg) group, trace 
FIG 2. Skin immunofluorescence patte rns after staining with flu -
o resceinated antimouse lgG, with chronic injection of 5 mg cationized 
rabbit lgG . Immune deposits at the DEJ (arrows) increased from 1 
week (A), to 3 weeks (B) , and declined slight ly at 4 weeks (C), but 
were still present at 7 weeks (D). X 400. 
TABLE Ill. Skin immunofluorescence intensity for rabbit JgG, mouse 
!gG, and mouse C3 in skin" 
1 Week 2 Wee ks 3 Weeks 4 Weeks 
RigG (1 mg) 
RlgG 1.5+ v 2+ v 1.5+ v 1.5+ v 
MlgG 1+ v/ 1+ d 1.5+ v/ 2+ d 1+ v/2+ d 1.5+v/ 2+d 
C3 1.5+ v 2+ v 1.5+ v 1.5+ v 
RigGED (1 mg) 
RlgG l+d 2+ d 1.5+ d/ tr D 1.5+ d/tr D 
MlgG l+d 3+ d 2+ d/tr D 3+ d/tr D 
C3 0 0 0 0 
a Sacrificed 4 h afte r last dose; v = vessels, d = diffuse perivascular, 
D = dermal-epidermal junction. 
FIG 3. Dermal blood vessel immunofluorescence patterns after 
staining with fluoresceinated antimouse fgG. After 3 weeks of chronic 
injections with native rabbit IgG , dermal vessels showed a discrete 
granular pattern (A) . After 3 weeks of chronic injections with cationic 
rabbit lgG, vessels had a more diffuse pattern (B) . These skin speci-
mens were examined 4 h after the last dose of antigen. X 400. 
TABLE IV. Renal immunofluorescence intensity (or mouse !gG" 
1 Week 2 Weeks 3 Weeks 4 Weeks 7 Weeks 
Glomerular 
RigGED (1 mg) 2+ 2.5+ 3+ 2.5+ 2.5+ 
RigG ED (5 mg) 2+ 3.5+ 4+ 4+ 3+ 
RlgG (1 mg) 1.5+ 2+ 2+ 2+ 2+ 
Extraglomerular 
RigG ED (1 mg) 1+ 1+ 1+ 0.5+ tr 
RigG ED (5 mg) 2+ 2+ 2+ 2+ 2+ 
RlgG (l mg) 0 0 0 0 0 
a Sacrificed 16 h after last dose. 
levels in the RigG (1 mg) group, and 1-2+ in the RigGED (5 
mg) group. No extraglomerular deposits of mouse C3 occurr~d. 
Histologic specimens of skin showed varying degrees of m-
flammation (Table V). Inflammatory infiltrates were predom-
inantly perivascular with mixed cell infiltrat ion in a deep 
dermal or subcutaneous location (Fig 5). The infiltrates were 
mostly lymphohistiocytic with sparse (< 10%) neutrophils. 
This react ion pattern was most marked in t he RlgG (1 mg) 
group where dense perivascular infiltrates occurred at 3-4 
weeks, even persisting to 7 weeks. Accumulation of inflamma-
tory cells was not seen at t he DEJ in any experimental group. 
Renal Histology, Proteinuria, and Electron Microscopy 
Kidney pathology did not differ significantly in any experi-
mental group at any time point but did show mild hypercellu -
larity and mesangial thickening, as compared to the control 
group. 
Proteinuria developed in all experimental groups at trace 
levels at 1- 2 weeks, and 1-2+ levels t hereafter; the BBS-treated 
groups had only 0-tr levels throughout t he study. 
Electron microscopy revealed subepithelial, as well as sub-
endothelial, mesangial, and interstitial deposits in the RigGED 
(5 mg) group more so than in the RigGED (1 mg) group, while 
the RigG (1 mg) group showed only mesangial deposits. 
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FIG 4. Kidney immunofluorescence patterns after sta ining wi th flu -
oresceinated antimouse !gG. On the left side, a mesangial glomerular 
pattern predom inates at 1 week (A), 3 weeks (C), and 7 weeks (E) 
after chronic injections of 1 mg rabbit IgG. For comparison, on the 
right, a glomerular capi llary loop pattern occurred after 1 week (B), 3 
weeks (D), and 7 weeks (F) of chronic injections of cationized rabbit 
lgG. Note the extraglomerular staining in (D) . X 400. 
TABLE V. Histologic degrees of periuasculor inflammation in skin 
tissues(! 
1 Week 2 Weeks 3 Weeks 4 Weeks 7 Weeks 
RigGED (1 mg) 1-2+ 1+ 1+ 1- 2+ 1+ 
Ri gGED (5 mg) 1+ 1+ 1- 2+ 1-2+ 1+ 
Rl gG (1 mg) 0 1+ 2+ 2-3+ 2+ 
BBS 0 0 0 0 0 
"Sacrificed 16 h after last dose. 
Level of Seru.m Antibody to Rabbit JgG 
As determined by t he radioimmunoassay, normal mouse sera 
had 11.11 ± 5.0% background antigen binding (Fig 6). Refer-
ence sera after 2 immunizations with heat-aggregated RigG, 
collected at day 0 before the chronic antigen administration, 
developed 51.3 ± 4.2% binding of 0.1 f..Lg antigen. The serum 
antibody levels in t he RigG ( 1 mg), RigGED (1 mg), and BBS 
groups did not vary significa ntly, except at 1 week when the 
RlgG (1 mg) group had a much higher measurable level. The 
RigGED (5 mg) group, however, had significantly lower serum 
ant ibody levels (p < .05) during the period of chronic antigen 
injections than in other groups of mice. At 7 weeks, all groups 
had similar serum antibody levels, which represented a signif-
icant increase for the RigGED (5 mg) group. 
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FIG 5. Hematoxylin and eosin stains of skin sections 3 weeks after 
chronic injections of native rabbit IgG. Note the mixed cell perivascular 
infiltrate (A) and more diffuse infiltrate (B) between hair follicles. 
X 400. 
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FIG 6. Antibody levels in different groups determined by radio-
immunoassay after 2 immunizations and during 4 weeks of chronic 
antigen injections. The native rabbit IgG (1 mg) group (.__.) 
developed the strongest measurable level at 1 week but did not differ 
significantly from the rabbit IgGED (1 mg) {0--0) and normal sa-
line group (A · · · A) at later time points. The rabbit IgGED (5 mg) 
(L> --L>) did not develop measurable levels differing from controls until 
7 weeks (3 weeks after injections were stopped). 
DISCUSSION 
The presented data indicate that antigen charge is an impor-
tant parameter determining tissue sites of immune deposit 
formation. Chronic administration of cationized rabbit lgG to 
immunized mice resulted in immune deposits at the DEJ while 
chronic administration of the same antigen in native form did 
not cause these deposits. The presence of immune complexes 
was inferred by immunofluorescence microscopy from the si-
multaneous appearance of antigen and antibody in concurrent 
sections. Schubert et al [15]. and Stanley et a l [16) have found 
that the interstitial space and the DEJ of the skin contain 
anionic glycoproteins. Thus, charge-charge interactions with 
cation ic macromolecules may be responsible for immune de-
posits at these sites. 
These deposits most likely represent a combination of in situ 
formatio n at the DEJ and intravascular formation with subse-
quent junctional localization of the complexes, as has been 
demonstrated previously for immune complexes with a cationic 
antibody [10). Extrapolating from our radioimmunoassay data, 
we can conclude that serum antibody represents a small frac-
tion of circulating lgG. Therefore, experimental conditions 
would favor a high degree of antigen excess, leading to small-
latticed complexes and free antigen available for in situ depo-
sition. Cationized rabbit IgG has been previously shown to have 
a rapid 2-phase clearance from circulation with less than 10% 
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remaining at 12 h after i.v. injection (11] . These conditions 
could decrease the level of antigen excess in circulation and 
favor form ation of large-lattice intravascular complexes. Apart 
from size, however, complexes with cationic constituents have 
electrostatic forces holding them to tissues. Indeed, junctional 
deposits persisted 3 weeks after the last injection of cationic 
antigen, suggesting very avid binding. 
The extraglomerular renal deposits paralleled the immune 
deposits at the DEJ in intensity, J:.ersistence, and linear mor-
phology. Glomerular deposits occurred in a capillary loop pat-
tern with increased complement deposition in the cationized 
antigen-stimulated groups, confirming the work of Gallo et al 
[1 7) after injection of cationic antigen. E lectron microscopy 
revealed subendothelial electron-dense deposits, greater than 
s ubepithelia l and extraglomeru lar ones, in the cationized anti-
gen groups, which were even more prominent in the higher dose 
group. The unaltered antigen group developed mesangial de-
pos its, as has also been previously reported [17]. 
Increasing the dose of cationized antigen (5 mg per injection) 
led to increased deposition in t he kidney as well as at t he DEJ. 
The low level of serum antibody in this group during the chronic 
antigen adm inistration, t herefore, must represent immune 
complex formation with the synt hesized antibody, contributing 
in part to enhanced tissue deposition . Despite the stepped-up 
deposition , mouse C3 could not be detected at t he DEJ. Mouse 
C3, however , was present in the glomeruli, indicating that 
complement-fixing antibodies to the injected antigen had been 
synthesized. Therefore, the reason for t he absence of C3 depos-
its at the DEJ may be related to the distance between fixed 
anionic sites at t he junction. If the distance is such that 
rearrangement or condensation into large deposits is not fa-
vored, contra ry to what has been observed in renal glomeruli 
[18], then the small -latticed complexes of cationic antigen and 
mouse an tibodies may not suffice for complement activation. 
Histologic Ram pies revealed pathologic changes of mixed cell , 
perivascular infiltration only in the dermis and subcutaneous 
tissue of the mice given the native antigen on the chronic 
schedule. Four hours after injection of antigen, vascular depo-
sition of antigen , antibody, and complement occurred in this 
group. The immunofluorescent staining pattern was similar to 
that seen after injection of a single bolus of preformed com-
plexes (10]. The cationic group had more diffuse perivascular 
and interstital deposits of antigen and antibody (Fig 3), but 
mouse C3 was absent. Complexes formed with unaltered rabbit 
lgG persist longer in circulation than those formed with cation-
ized rabbit IgG [11]. This factor may have contributed to 
enhanced deposition of immune complexes in small dermal 
vessels. 
These vascular and perivascular immune deposits were not 
detectable 16 h after antigen injection. After a single i.v. bolus 
of preformed complexes immune deposits were previously 
shown to be waning after 12 h [10) . Also, immune deposits 
were not detectable in dermal vessels of guinea pigs 8-18 h 
after induction of an Arthus reaction [19]. Furthermore, in 
patients with small-vessel vasculitis lesions over 24 h old, 
immune deposits could no longer be found [20] . Phagocytosis 
of immune complexes is the most likely cause for the brief 
presence of immune deposits, since neutrophils were seen by 
16 h after antigen injection. Thus, t he inflammation in vessels 
is related to transient deposition of immune complexes and 
complement components. 
These experiments show that the charge properties of circu-
lating antigens a re important in quantitative and site-specific 
formation of deposits. The DEJ is accessible to intravascular 
cationic antigens, and can lead to antibody deposition at this 
site. The data presented here document this in a chronic serum 
sickness model in mice. A previous study indicated that posi-
tively charged immune complexes have access to this site from 
circulation (10]. These studies collectively suggest that the DEJ 
deposits of immunoglobulins in human diseases also may arise 
by charge-charge interactions. The fixed negative charges at 
the DEJ may bind positively charged immune complexes, if 
these complexes can reach the DEJ. Alternatively, positively 
charged antigens can bind to t hese negative charges and then 
combine with antibodies to form immune deposits locally. 
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